In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
source https://www.nytimes.com/2026/03/19/health/ozempic-wegovy-generic-india-china-canada.html
0 Comments